Возраст домена | 13 лет |
Дата окончания | Истек срок регистрации |
PR | 4 |
ИКС | n/a |
Страниц в Google | 2070 |
Страниц в Яндексе | 4 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 3466497 |
Alexa Country | 1606371 |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Home - Translational Cancer Research
Breast cancer, risk assessment, cellular and prevention, detection, diagnosis
Translational Cancer Research publishes the results of novel research investigations including risk assessment, cellular and prevention, detection, diagnosis and treatment of human cancers.
UTF-8
345.59 КБ
2 500
69 349 симв.
59 220 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
nih.gov | 46 | 8 |
0 | 113 | 65 | |
nature.com | 33 | 9 |
0 | 740 | 269 | |
wikipedia.org | 29 | 9 |
0 | 5 | 6 | |
oxfordjournals.org | 19 | 9 |
0 | 326878 | 158401 | |
aacrjournals.org | 19 | 7 |
0 | 22356 | 8487 | |
youtube.com | 15 | 9 |
0 | 2 | 2 | |
sciencedirect.com | 15 | 9 |
0 | 172 | 94 | |
cshlp.org | 12 | 3 |
0 | 27434 | 15689 | |
jbc.org | 11 | 7 |
120 | 18897 | 11305 | |
cell.com | 10 | 7 |
650 | 6602 | 2551 | |
Еще 40 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Ссылок в Alexa | 28 |
Данные linkpad ( 11 Апреля 2014 ) | |
Количество ссылок на сайт | 1640 |
Количество доменов, которые ссылаются на сайт | 14 |
Количество найденных анкоров | 4 |
Исходящие (внешние) ссылки домена | 1896 |
Количество доменов, на которые ссылается сайт | 23 |
Количество исходящих анкоров | 23 |
Внешние ссылки главной страницы ( 471 ) | |
ebook.amegroups.cn/app/sciJournals-en-US | <img> |
tcr.amegroups.com/login | Log In |
tcr.amegroups.com/user/register | Register |
tcr.amegroups.com/ | Translational Cancer Research |
tcr.amegroups.com/search | Advanced Search |
tcr.amegroups.com/index | Home |
tcr.amegroups.com/about | Aims and scope Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tc... |
tcr.amegroups.com/about/editorInChief | Editor-in-Chief |
tcr.amegroups.com/about/editorialTeam | Editorial Board |
tcr.amegroups.com/about/sectionEditors | Section Editors |
tcr.amegroups.com/about/formereditor | Former Editorial Board |
tcr.amegroups.com/author/submit | Online Submission |
editing.amegroups.cn/ | Translation |
tcr.amegroups.com/reviewer | Online Review |
tcr.amegroups.com/issue/current | Current Issue |
tcr.amegroups.com/issue/archive | Archives |
tcr.amegroups.com/issue/publishAheadOfPrint | Online First |
tcr.amegroups.com/announcement | more |
tcr.amegroups.com/announcement/view/245 | More >> |
tcr.amegroups.com/issue/view/400 | Read More>> |
tcr.amegroups.com/post/view/focused-issue-on-urothelial-carc... | More >> |
tcr.amegroups.com/post/view/focused-issue-on-loco-regional-t... | More >> |
tcr.amegroups.com/post/view/focused-issue-on-energy-balance-... | Read More>> |
tcr.amegroups.com/post/view/focused-issue-on-tumor-immune-mi... | Read More>> |
tcr.amegroups.com/post/view/focused-issue-on-oral-pre-cancer... | Read More>> |
tcr.amegroups.com/issue/view/296 | Read More>> |
tcr.amegroups.com/issue/view/288 | Read More>> |
tcr.amegroups.com/issue/current/showToc | Vol 8, No 8 (December, 2019) |
tcr.amegroups.com/pages/view/reprint | Reprint |
tcr.amegroups.com/pages/view/permission | Permission |
tcr.amegroups.com/pages/view/sponsored-supplements | Sponsored Supplements |
tcr.amegroups.com/pages/view/advertising | Advertising |
tcr.amegroups.com/announcement/view/244 | More >> |
tcr.amegroups.com/announcement/view/239 | More >> |
tcr.amegroups.com/post/category/meet-the-professor | more |
tcr.amegroups.com/post/view/theresa-l-whiteside-if-you-belie... | More >> |
tcr.amegroups.com/post/view/maria-g-castro-science-is-a-high... | More >> |
tcr.amegroups.com/post/view/louis-dubeau-putting-aside-biase... | More >> |
tcr.amegroups.com/article/view/33287 | Clinical significance of serum tumor markers for advanced gastric cancer with the first-line chemotherapy |
tcr.amegroups.com/article/view/33287/pdf | PDF Pages: 2680-2690 |
tcr.amegroups.com/article/view/33287/html | Full Text |
copyright.com/ccc/openurl.do?issn=2218-676X&WT.mc.id=AME Pub... | <img> |
tcr.amegroups.com/article/view/33286 | Down-regulated hsa_circ_0067934 facilitated the progression of gastric cancer by sponging hsa-mir-4705 to downgrade the expressi... |
tcr.amegroups.com/article/view/33286/pdf | PDF Pages: 2691-2703 |
tcr.amegroups.com/article/view/33286/html | Full Text |
tcr.amegroups.com/article/view/33288 | Reduced RANBP9 expression is associated with poor prognosis in colorectal cancer patients |
tcr.amegroups.com/article/view/33288/pdf | PDF Pages: 2704-2712 |
tcr.amegroups.com/article/view/33288/html | Full Text |
tcr.amegroups.com/article/view/33497 | MicroRNA-200c affects bladder cancer angiogenesis by regulating the Akt2/mTOR/HIF-1 axis |
tcr.amegroups.com/article/view/33497/pdf | PDF Pages: 2713-2724 |
tcr.amegroups.com/article/view/33497/html | Full Text |
tcr.amegroups.com/article/view/33438 | ADAMTS-1 inhibits angiogenesis via the PI3K/Akt-eNOS-VEGF pathway in lung cancer cells |
tcr.amegroups.com/article/view/33438/pdf | PDF Pages: 2725-2735 |
tcr.amegroups.com/article/view/33438/html | Full Text |
tcr.amegroups.com/article/view/34345 | Analysis of volatile organic compounds released from SW480 colorectal cancer cells and the blood of tumor-bearing mice |
tcr.amegroups.com/article/view/34345/pdf | PDF Pages: 2736-2751 |
tcr.amegroups.com/article/view/34345/html | Full Text |
tcr.amegroups.com/article/view/33289 | Predictive value of preoperative weight loss on survival of elderly patients undergoing surgery for esophageal squamous cell car... |
tcr.amegroups.com/article/view/33289/pdf | PDF Pages: 2752-2758 |
tcr.amegroups.com/article/view/33289/html | Full Text |
tcr.amegroups.com/article/view/33336 | HDAC6 inhibitor WT161 induces apoptosis in retinoblastoma cells and synergistically interacts with cisplatin |
tcr.amegroups.com/article/view/33336/pdf | PDF Pages: 2759-2768 |
tcr.amegroups.com/article/view/33336/html | Full Text |
tcr.amegroups.com/article/view/33129 | LncRNA CASC9 regulates cell proliferation, apoptosis and cell cycle via sponging miR-145-5p in colon cancer cells |
tcr.amegroups.com/article/view/33129/pdf | PDF Pages: 2769-2780 |
tcr.amegroups.com/article/view/33129/html | Full Text |
tcr.amegroups.com/article/view/33822 | The application of methylene blue coloration technique in axillary lymph node dissection of breast cancer |
tcr.amegroups.com/article/view/33822/pdf | PDF Pages: 2781-2790 |
tcr.amegroups.com/article/view/33822/html | Full Text |
tcr.amegroups.com/article/view/33235 | miR-203a-3p regulates the cellular processes of esophageal cancer cells via targeting CtBP2 |
tcr.amegroups.com/article/view/33235/pdf | PDF Pages: 2791-2802 |
tcr.amegroups.com/article/view/33235/html | Full Text |
tcr.amegroups.com/article/view/33233 | (rs25487, G1196A) polymorphism detection as an effective screening panel for genitourinary system cancers |
tcr.amegroups.com/article/view/33233/pdf | PDF Pages: 2803-2812 |
tcr.amegroups.com/article/view/33233/html | Full Text |
tcr.amegroups.com/article/view/33318 | infection and lung cancer: a meta-analysis |
tcr.amegroups.com/article/view/33318/pdf | PDF Pages: 2813-2819 |
tcr.amegroups.com/article/view/33318/html | Full Text |
tcr.amegroups.com/article/view/33314 | Selective lymph node dissection for clinical T1 stage non-small cell lung cancer |
tcr.amegroups.com/article/view/33314/pdf | PDF Pages: 2820-2828 |
tcr.amegroups.com/article/view/33314/html | Full Text |
tcr.amegroups.com/article/view/34519 | Identification of key protein-coding genes in lung adenocarcinomas based on bioinformatic analysis |
tcr.amegroups.com/article/view/34519/pdf | PDF Pages: 2829-2840 |
tcr.amegroups.com/article/view/34519/html | Full Text |
tcr.amegroups.com/article/view/33668 | Plasma enhance drug sensitivity to bortezomib by inhibition of cyp1a1 in myeloma cells |
tcr.amegroups.com/article/view/33668/pdf | PDF Pages: 2841-2847 |
tcr.amegroups.com/article/view/33668/html | Full Text |
tcr.amegroups.com/article/view/33727 | An improved method to build lung cancer PDX models by surgical resection samples and its association with B7-H3 expression |
tcr.amegroups.com/article/view/33727/pdf | PDF Pages: 2848-2857 |
tcr.amegroups.com/article/view/33727/html | Full Text |
tcr.amegroups.com/article/view/33231 | mutation detected in ctDNA by ddPCR |
tcr.amegroups.com/article/view/33231/pdf | PDF Pages: 2858-2863 |
tcr.amegroups.com/article/view/33231/html | Full Text |
tcr.amegroups.com/article/view/34077 | Utilization of combined PD-L1 expression and neutrophil-to-lymphocyte ratio prior to surgery as a prognostic factor in non-small... |
tcr.amegroups.com/article/view/34077/pdf | PDF Pages: 2864-2877 |
tcr.amegroups.com/article/view/34077/html | Full Text |
tcr.amegroups.com/article/view/33658 | Dosimetric comparison of dose accumulation between rigid registration and deformation registration in intensity-modulated radiat... |
tcr.amegroups.com/article/view/33658/pdf | PDF Pages: 2878-2885 |
tcr.amegroups.com/article/view/33658/html | Full Text |
tcr.amegroups.com/article/view/33715 | Study of the dose-volume parameters variation in tumor target volumes and organs at risk during nasopharyngeal carcinoma radioth... |
tcr.amegroups.com/article/view/33715/pdf | PDF Pages: 2886-2892 |
tcr.amegroups.com/article/view/33715/html | Full Text |
tcr.amegroups.com/article/view/34143 | Study on the differences of opinions and choices of high-risk breast cancer populations in China before and after genetic testin... |
tcr.amegroups.com/article/view/34143/pdf | PDF Pages: 2893-2905 |
tcr.amegroups.com/article/view/34143/html | Full Text |
tcr.amegroups.com/article/view/34433 | Girdin knockdown promotes apoptosis in colorectal cancer via miR-29c-3p/Girdin axis |
tcr.amegroups.com/article/view/34433/pdf | PDF Pages: 2906-2915 |
tcr.amegroups.com/article/view/34433/html | Full Text |
tcr.amegroups.com/article/view/33236 | Disorders of neural crest derivates in oncoradiological practice |
tcr.amegroups.com/article/view/33236/pdf | PDF Pages: 2916-2923 |
tcr.amegroups.com/article/view/33236/html | Full Text |
tcr.amegroups.com/article/view/33232 | Invasive mucinous adenocarcinoma of the lung |
tcr.amegroups.com/article/view/33232/pdf | PDF Pages: 2924-2932 |
tcr.amegroups.com/article/view/33232/html | Full Text |
tcr.amegroups.com/article/view/33709 | Primary lung cancer firstly presents as nephrotic syndrome: one case report and literature review |
tcr.amegroups.com/article/view/33709/pdf | PDF Pages: 2933-2935 |
tcr.amegroups.com/article/view/33709/html | Full Text |
tcr.amegroups.com/article/view/34328 | Skeletal muscle metastasis from squamous cell lung cancer was first found by ultrasound: a case report |
tcr.amegroups.com/article/view/34328/pdf | PDF Pages: 2936-2940 |
tcr.amegroups.com/article/view/34328/html | Full Text |
tcr.amegroups.com/article/view/34076 | PD-1/PD-L1 inhibitors as a hope for smokers of non-small cell lung cancer patient |
tcr.amegroups.com/article/view/34076/pdf | PDF Pages: 2941-2943 |
tcr.amegroups.com/article/view/34076/html | Full Text |
tcr.amegroups.com/article/view/30099 | The tango of immunotherapy and targeted therapy in metastatic renal cell carcinoma |
tcr.amegroups.com/article/view/30099/pdf | PDF Pages: E1-E6 |
tcr.amegroups.com/article/view/30099/html | Full Text |
tcr.amegroups.com/article/view/34075 | Role of artificial intelligence in integrated analysis of multi-omics and imaging data in cancer research |
tcr.amegroups.com/article/view/34075/pdf | PDF Pages: E7-E10 |
tcr.amegroups.com/article/view/34075/html | Full Text |
tcr.amegroups.com/article/view/34518 | Addition of atezolizumab to nab-paclitaxel plus carboplatin is a new standard option for the first-line treatment for non-squamo... |
tcr.amegroups.com/article/view/34518/pdf | PDF Pages: E11-E14 |
tcr.amegroups.com/article/view/34518/html | Full Text |
tcr.amegroups.com/article/view/34517 | N-Myc a key gene promoting a worst prostate cancer progression |
tcr.amegroups.com/article/view/34517/pdf | PDF Pages: E15-E17 |
tcr.amegroups.com/article/view/34517/html | Full Text |
tcr.amegroups.com/article/view/34515 | Carboplatin, nab-paclitaxel plus atezolizumab in Impower 130 trial: new weapons beyond controversies |
tcr.amegroups.com/article/view/34515/pdf | PDF Pages: E18-E23 |
tcr.amegroups.com/article/view/34515/html | Full Text |
tcr.amegroups.com/article/view/962 | Common applications of next-generation sequencing technologies in genomic research |
tcr.amegroups.com/article/view/788 | Targetting the PD-L1/PD-1 axis holds promise in the treatment of malignancy |
tcr.amegroups.com/article/view/961 | Prognostic value of TTF-1 expression in patients with non-small cell lung cancer: a meta-analysis |
tcr.amegroups.com/article/view/964 | Is there still a role for tremelimumab in the treatment of cancer? |
tcr.amegroups.com/article/view/1152 | Alternative pathways of non-homologous end joining (NHEJ) in genomic instability and cancer |
tcr.amegroups.com/article/view/1132 | DNA damage tolerance: a double-edged sword guarding the genome |
tcr.amegroups.com/article/view/1550 | Nanoparticles in radiation therapy: a summary of various approaches to enhance radiosensitization in cancer |
tcr.amegroups.com/article/view/383 | MDM2 and MDMX: alone and together in regulation of p53 |
tcr.amegroups.com/article/view/595 | Historical perspective and evolution of charged particle beam therapy |
tcr.amegroups.com/article/view/1549 | Tumor microenvironment and nanotherapeutics |
tcr.amegroups.com/article/view/1097 | Role of NBS1 in DNA damage response and its relationship with cancer development |
tcr.amegroups.com/article/view/1547 | Gold nanoparticles in radiation research: potential applications for imaging and radiosensitization |
tcr.amegroups.com/article/view/543 | Proton therapy for gastrointestinal cancers |
tcr.amegroups.com/article/view/786 | Proton therapy for head and neck cancer: current applications and future directions |
tcr.amegroups.com/article/view/1219 | DNA ligases as therapeutic targets |
tcr.amegroups.com/article/view/372 | Normal tissue protection for improving radiotherapy: where are the Gaps? |
tcr.amegroups.com/article/view/1080 | DNA crosslinking damage and cancer - a tale of friend and foe |
tcr.amegroups.com/article/view/371 | Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatment |
tcr.amegroups.com/article/view/1674 | Hematopoietic stem cell senescence and cancer therapy-induced long-term bone marrow injury |
tcr.amegroups.com/article/view/811 | Comparison of tissue characterization curves for different CT scanners: implication in proton therapy treatment planning |
tcr.amegroups.com/article/view/4536 | Cancer biomarker discovery and validation |
tcr.amegroups.com/article/view/19860 | Clinical relevance of liquid biopsy for cancer screening |
tcr.amegroups.com/article/view/1142 | DNA double strand break repair via non-homologous end-joining |
tcr.amegroups.com/article/view/370 | is a tumor suppressor that connects aging, acetylome, cell cycle signaling, and carcinogenesis |
tcr.amegroups.com/article/view/1638 | Role of p53 in regulating tissue response to radiation by mechanisms independent of apoptosis |
tcr.amegroups.com/article/view/599 | Improving the precision and performance of proton pencil beam scanning |
tcr.amegroups.com/article/view/1514 | Radiosensitization by gold nanoparticles: effective at megavoltage energies and potential role of oxidative stress |
tcr.amegroups.com/article/view/1380 | Intestinal stem cell injury and protection during cancer therapy |
tcr.amegroups.com/article/view/1342 | Third generation gold nanoplatform optimized for radiation therapy |
tcr.amegroups.com/article/view/2091 | Immune effects of high dose radiation treatment: implications of ionizing radiation on the development of bystander and abscopal... |
tcr.amegroups.com/article/view/10643 | Targeted attack: mechanisms by which ovarian cancers suppress the immune system |
tcr.amegroups.com/article/view/1497 | Focusing in on radiation induced brain injury |
tcr.amegroups.com/article/view/19798 | Targeting HSP90 in malignant gliomas: onalespib as a potential therapeutic |
tcr.amegroups.com/article/view/20301 | Lessons learned from rindopepimut treatment in patients with EGFRvIII-expressing glioblastoma |
tcr.amegroups.com/article/view/21678 | Gut microbes modulate host response to immune checkpoint inhibitor cancer immunotherapy |
tcr.amegroups.com/article/view/20950 | New light on the pancreatic cyst conundrum |
tcr.amegroups.com/article/view/8896 | HNF1A, KRT81, and CYP3A5: three more straws on the back of pancreatic cancer? |
tcr.amegroups.com/article/view/26689 | (R)-2-hydroxyglutarate drives immune quiescence in the tumor microenvironment of IDH-mutant gliomas |
tcr.amegroups.com/article/view/25656 | On the subventricular zone origin of human glioblastoma |
tcr.amegroups.com/article/view/23048 | Are lung adenocarcinoma mutations shaping the immune microenvironment? |
tcr.amegroups.com/article/view/23514 | Bevacizumab as an adjuvant therapy for glioblastoma in elderly patients: the facts |
tcr.amegroups.com/article/view/23480 | rearrangements in non-small cell lung cancer with crizotinib and other kinase inhibitors |
tcr.amegroups.com/article/view/20613 | Disulfiram combats cancer via crippling valosin-containing protein/p97 segregase adaptor NPL4 |
tcr.amegroups.com/article/view/19924 | Hypofractionated whole breast irradiation is cost-effective—but is that enough to change practice? |
tcr.amegroups.com/article/view/18411 | Cost-effectiveness in managing skeletal related events in breast cancer: a strategy of less-intense dosing schedule of bone modi... |
tcr.amegroups.com/article/view/18387 | CRISPR-based genetic interaction maps inform therapeutic strategies in cancer |
tcr.amegroups.com/article/view/17878 | Smooth sailing for immunotherapy for unresectable stage III nonsmall cell lung cancer: the PACIFIC study |
tcr.amegroups.com/article/view/17612 | The evolving role of molecular profiling in prostate cancer: basal and luminal subtyping transcends tissue of origin |
tcr.amegroups.com/article/view/17473 | Serrated polyposis: the problem of definition and its relationship to the population at risk for syndrome-related colorectal ca... |
tcr.amegroups.com/article/view/17154 | Multifactorial regulators of tumor programmed death-ligand 1 (PD-L1) response |
tcr.amegroups.com/article/view/17067 | Therapeutic targeting of oncogenic KRAS in pancreatic cancer by engineered exosomes |
tcr.amegroups.com/article/view/16986 | TIC10/ONC201—a potential therapeutic in glioblastoma |
tcr.amegroups.com/article/view/16582 | IDH mutational status and the immune system in gliomas: a tale of two tumors? |
tcr.amegroups.com/article/view/16323 | ONC201: a new treatment option being tested clinically for recurrent glioblastoma |
tcr.amegroups.com/article/view/16322 | When better still might not be good enough |
tcr.amegroups.com/article/view/15649 | Androgen receptor antagonism and impact on inhibitors of androgen synthesis in prostate cancer therapy |
tcr.amegroups.com/article/view/15076 | Co-inhibitory receptor programmed cell death protein 1 targets co-stimulatory CD28 |
tcr.amegroups.com/article/view/14924 | Exosome mediated phenotypic changes in lung cancer pathophysiology |
tcr.amegroups.com/article/view/14122 | Signatures of field cancerization: a step towards earlier detection of esophageal adenocarcinoma |
tcr.amegroups.com/article/view/14119 | From tumorigenesis to microenvironment and immunoregulation: the many faces of focal adhesion kinase and challenges associated w... |
tcr.amegroups.com/article/view/13961 | New incriminating evidence against IGF2 |
tcr.amegroups.com/article/view/13585 | Targeting cancer with tumor-specific therapeutic strategies—metabolic reprogramming beyond the Warburg effect |
tcr.amegroups.com/article/view/13584 | Branched chain amino acid metabolism and cancer: the importance of keeping things in context |
tcr.amegroups.com/article/view/13352 | RIPK1-TRAF2 interplay on the TNF/NF-κB signaling, cell death, and cancer development in the liver |
tcr.amegroups.com/article/view/12824 | Genome-based modeling for adjusting radiotherapy dose (GARD)-a significant step toward the future of personalized radiation ther... |
tcr.amegroups.com/article/view/12819 | Rogue one: another faction of the Wnt empire implicated in assisting GBM progression |
tcr.amegroups.com/article/view/12818 | Normalizing tumoral vessels to treat cancer: an out-of-the-box strategy involving TIE2 pathway |
tcr.amegroups.com/article/view/12816 | Exploring gold nanoparticle interactions with proteins and the tumor microenvironment in biological systems |
tcr.amegroups.com/article/view/12812 | IL-6, cancer and cachexia: metabolic dysfunction creates the perfect storm |
tcr.amegroups.com/article/view/12811 | Low-frequency ultrasound may improve drug penetration in colonic mucosa |
tcr.amegroups.com/article/view/12644 | lung cancer |
tcr.amegroups.com/article/view/12604 | Unlocking the epigenetic code of T cell exhaustion |
tcr.amegroups.com/article/view/12511 | KDM1 links nuclear GSK3β to epigenetic alterations |
tcr.amegroups.com/article/view/12240 | Moving the mountain in advanced non-small-cell lung cancer: evolving immunotherapies for a dire disease |
tcr.amegroups.com/article/view/12063 | Taming immune suppressor: application of myeloid-derived suppressor cells in anti-cancer gene therapy |
tcr.amegroups.com/article/view/11869 | Neuroendocrine differentiation in prostate cancer: key epigenetic players |
tcr.amegroups.com/article/view/11305 | PD-L1 is a diverse molecule regulating both tumor-intrinsic signaling and adaptive immunosuppression |
tcr.amegroups.com/article/view/10754 | Mesenchymal stromal cells and interferon α (IFNα) in cancer immunotherapy |
tcr.amegroups.com/article/view/10421 | The potential role of curcumin in prostate cancer: the importance of optimizing pharmacokinetics in clinical studies |
tcr.amegroups.com/article/view/10419 | Information-dense analysis for information-dense understanding |
tcr.amegroups.com/article/view/10121 | The “liquid biopsy” in non-small cell lung cancer—not quite ready for prime time use |
tcr.amegroups.com/article/view/10016 | Immune infiltration, glioma stratification, and therapeutic implications |
tcr.amegroups.com/article/view/9385 | Balancing redox stress: anchorage-independent growth requires reductive carboxylation |
tcr.amegroups.com/article/view/9016 | Myeloid leukemia switch as immune escape from CD19 chimeric antigen receptor (CAR) therapy |
tcr.amegroups.com/article/view/8959 | Harnessing protein kinase A activation to induce mesenchymal-epithelial programs to eliminate chemoresistant, tumor-initiating b... |
tcr.amegroups.com/article/view/8952 | Actionable intelligence provided by pancreatic cancer genomic landscape: are targets for curative therapy on the map? |
tcr.amegroups.com/article/view/8101 | Microtubule targeting agents in glioma |
tcr.amegroups.com/article/view/8029 | Moving molecular subtypes to the clinic in gastric cancer |
tcr.amegroups.com/article/view/7706 | Intraoperative subtyping of lung adenocarcinoma: an unmet need |
tcr.amegroups.com/article/view/6391 | Emerging roles of FGF signaling in hepatocellular carcinoma |
tcr.amegroups.com/article/view/10126 | Tregs, Helios and tumor immunity: the sun has not yet risen |
tcr.amegroups.com/article/view/9964 | Immune checkpoint regulator: a new assignment proposed for the classic adhesion molecule P-selectin glycoprotein ligand-1 |
tcr.amegroups.com/article/view/8722 | Sarcomatoid renal cell carcinoma: genomic insights from sequencing of matched sarcomatous and carcinomatous components |
tcr.amegroups.com/article/view/13587 | Epigenetic regulation of PD-L1 expression and pancreatic cancer response to checkpoint immunotherapy |
tcr.amegroups.com/article/view/12642 | loss |
tcr.amegroups.com/article/view/2649 | A recursively partitioned mixture model for clustering time-course gene expression data |
tcr.amegroups.com/article/view/2652 | Statistical strategies for microRNAseq batch effect reduction |
tcr.amegroups.com/article/view/1309 | Defining functional changes in the brain caused by targeted stereotaxic radiosurgery |
tcr.amegroups.com/article/view/387 | A chain reaction approach to modelling gene pathways |
tcr.amegroups.com/article/view/369 | Oncolytic virus-mediated tumor radiosensitization in mice through DNA-PKcs-specific shRNA |
tcr.amegroups.com/article/view/2650 | Identification of cancer mechanisms through computational systems modeling |
tcr.amegroups.com/article/view/2875 | Frameless single-isocenter intensity modulated stereotactic radiosurgery for simultaneous treatment of multiple intracranial met... |
tcr.amegroups.com/article/view/21818 | Matrix metalloproteinase (MMP) and immunosuppressive biomarker profiles of seven head and neck squamous cell carcinoma (HNSCC) c... |
tcr.amegroups.com/article/view/25724 | Quantitative ubiquitylome analysis and crosstalk with proteome/ acetylome analysis identified novel pathways and targets of peri... |
tcr.amegroups.com/article/view/10187 | Coexpression and expression quantitative trait loci analyses of the angiogenesis gene-gene interaction network in prostate cance... |
tcr.amegroups.com/article/view/10186 | How are lung cancer risk perceptions and cigarette smoking related?—testing an accuracy hypothesis |
tcr.amegroups.com/article/view/9248 | Butyrate consumption of differentiated colonocytes in the upper crypt promotes homeostatic proliferation of stem and progenitor ... |
tcr.amegroups.com/article/view/2648 | Integrative clustering methods for high-dimensional molecular data |
tcr.amegroups.com/article/view/2646 | Sparse principal component analysis in cancer research |
tcr.amegroups.com/article/view/2651 | An improved understanding of cancer genomics through massively parallel sequencing |
tcr.amegroups.com/article/view/3930 | Pathogenesis of serous, extra-uterine Müllerian epithelial cancer and therapeutic implications |
tcr.amegroups.com/article/view/3806 | The promise and challenge of ovarian cancer models |
tcr.amegroups.com/article/view/20797 | Role of the androgen signaling axis in genitourinary malignancies |
tcr.amegroups.com/article/view/19036 | Prostate cancer: unmet clinical needs and RAD9 as a candidate biomarker for patient management |
tcr.amegroups.com/article/view/16938 | Exosomal lncRNAs as new players in cell-to-cell communication |
tcr.amegroups.com/article/view/14117 | Repurposing DNA repair factors to eradicate tumor cells upon radiotherapy |
tcr.amegroups.com/article/view/14113 | Translational research in radiation-induced DNA damage signaling and repair |
tcr.amegroups.com/article/view/14112 | Genetically engineered mouse models for studying radiation biology |
tcr.amegroups.com/article/view/13604 | Renal cell carcinoma: the search for a reliable biomarker |
tcr.amegroups.com/article/view/12202 | Advances on immunotherapy in genitourinary and renal cell carcinoma |
tcr.amegroups.com/article/view/11958 | The role of novel immunotherapies in non-Hodgkin lymphoma |
tcr.amegroups.com/article/view/11261 | MDMX under stress: the MDMX-MDM2 complex as stress signals hub |
tcr.amegroups.com/article/view/11241 | Do p53 stress responses impact organismal aging? |
tcr.amegroups.com/article/view/11096 | Pharmacological targeting of mutant p53 |
tcr.amegroups.com/article/view/10906 | Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis |
tcr.amegroups.com/article/view/10795 | Regulation of cytotoxic T-cell responses by p53 in cancer |
tcr.amegroups.com/article/view/9527 | The IGF-1R/AKT pathway determines cell fate in response to p53 |
tcr.amegroups.com/article/view/9514 | Intra molecular interactions in the regulation of p53 pathway |
tcr.amegroups.com/article/view/9452 | TP53 mutations in epithelial ovarian cancer |
tcr.amegroups.com/article/view/9306 | Modulation of the p53 family network by RNA-binding proteins |
tcr.amegroups.com/article/view/8805 | Radiomics in head and neck cancer: from exploration to application |
tcr.amegroups.com/article/view/8705 | Prostate cancer radiomics and the promise of radiogenomics |
tcr.amegroups.com/article/view/8670 | Positron emission tomography/computerized tomography for tumor response assessment—a review of clinical practices and radiomics ... |
tcr.amegroups.com/article/view/8579 | The emerging field of radiomics in esophageal cancer: current evidence and future potential |
tcr.amegroups.com/article/view/5491 | Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat’s in the fire |
tcr.amegroups.com/article/view/2594 | Computational methods and opportunities for phosphorylation network medicine |
tcr.amegroups.com/article/view/12230 | Molecular heterogeneity of localized prostate cancer: more different than alike |
tcr.amegroups.com/article/view/12089 | A crowded, but still varied, space: brigatinib in anaplastic lymphoma kinase-rearranged non-small cell lung cancer |
tcr.amegroups.com/article/view/12075 | MOAP-1, UBR5 and cisplatin resistance in ovarian cancer |
tcr.amegroups.com/article/view/12061 | Exportin 1/chromosome region maintenance 1 as a therapeutic target for lung cancer |
tcr.amegroups.com/article/view/12030 | The role of tumor-derived exosomes in epithelial mesenchymal transition (EMT) |
tcr.amegroups.com/article/view/11325 | F]-choline PET/CT as an imaging biomarker for primary liver cancers |
tcr.amegroups.com/article/view/11321 | therapy—10-day concomitant, bismuth quadruple or 14-day triple therapy: none is best |
tcr.amegroups.com/article/view/10763 | JAK3-mediated phosphorylation of EZH2: a novel mechanism of non-canonical EZH2 activation and oncogenic function |
tcr.amegroups.com/article/view/10420 | Cisplatin, etoposide, and irinotecan for relapsed small-cell lung cancer |
tcr.amegroups.com/article/view/9526 | vacuolating cytotoxin and gastric cancer risk: reconsidered |
tcr.amegroups.com/article/view/9237 | Colonic crypts are natural gatekeepers of microbial metabolites to protect stem cells |
tcr.amegroups.com/article/view/8828 | Helios—controller of Treg stability and function |
tcr.amegroups.com/article/view/8800 | Directing abiraterone metabolism: balancing the scales between clinical relevance and experimental observation |
tcr.amegroups.com/article/view/8176 | Novel insights into the oncogenic function of the SMYD3 lysine methyltransferase |
tcr.amegroups.com/article/view/7942 | Fat lure: adipocytes attract cancer cells out of the prostate |
tcr.amegroups.com/article/view/7695 | Impact of genomic heterogeneity associated with acquired anti-EGFR resistance in colorectal cancers |
tcr.amegroups.com/article/view/1116 | Into the eye of the storm: breast cancer’s somatic mutation landscape points to DNA damage and repair |
tcr.amegroups.com/article/view/21699 | Circular RNAs and competing endogenous RNA (ceRNA) networks |
tcr.amegroups.com/article/view/9535 | The STAMPEDE trial: paradigm-changing data through innovative trial design |
tcr.amegroups.com/article/view/9473 | Regulation of chemo-sensitivity in ovarian cancer via a stroma dependent glutathione pathway |
tcr.amegroups.com/article/view/9296 | Feed your gut with caution! |
tcr.amegroups.com/article/view/8072 | Precision oncology: identifying predictive biomarkers for the treatment of metastatic renal cell carcinoma |
tcr.amegroups.com/article/view/18248 | Multiscale modeling of glioblastoma |
tcr.amegroups.com/article/view/414 | A balancing act for breast cancer? Everolimus for hormone receptor positive patients |
tcr.amegroups.com/article/view/598 | New developments in treatment planning and verification of particle beam therapy |
tcr.amegroups.com/article/view/1548 | Externally modulated theranostic nanoparticles |
tcr.amegroups.com/article/view/1415 | Cancer stem cells in glioma: challenges and opportunities |
tcr.amegroups.com/article/view/1546 | Convergence of nanotechnology with radiation therapy—insights and implications for clinical translation |
tcr.amegroups.com/article/view/378 | Sensitization of tumor cells to cancer therapy by molecularly targeted inhibition of the inhibitor of nuclear factor κB kinase |
tcr.amegroups.com/article/view/1511 | Improving chemoradiotherapy with nanoparticle therapeutics |
tcr.amegroups.com/article/view/1676 | Molecular mechanisms involved in tumor repopulation after radiotherapy |
tcr.amegroups.com/article/view/1763 | Efficacy of combination treatment modalities for intermediate and advanced hepatocellular carcinoma: intra-arterial therapies, s... |
tcr.amegroups.com/article/view/959 | Utilizing signature-score to identify oncogenic pathways of cholangiocarcinoma |
tcr.amegroups.com/article/view/33858 | A fatal myelosuppression, diarrhea and neurotoxicity induced by combination of irinotecan and tegafur-gimeracil-oteracil potassi... |
tcr.amegroups.com/article/view/34096 | Histologic transformation of lung adenocarcinoma to squamous cell carcinoma after chemotherapy: two case reports |
tcr.amegroups.com/article/view/34603 | Decitabine as a treatment choice for de novo acute basophilic leukemia: transient response-a case report |
tcr.amegroups.com/article/view/34689 | A recurrence of advanced malignant sex cord tumor with annular tubules: case report |
tcr.amegroups.com/article/view/30247 | Evaluation of acute skin toxicity during radiotherapy for breast cancer in elderly patients |
tcr.amegroups.com/article/view/30484 | Adjuvant whole breast radiotherapy with simultaneous integrated boost to tumor bed with intensity modulated radiotherapy techniq... |
tcr.amegroups.com/article/view/33439 | Overexpression of hyaluronan-binding protein 1 promotes the proliferation, migration, and invasion of malignant glioma |
tcr.amegroups.com/article/view/30485 | Post mastectomy radiotherapy for elderly patients with intermediate risk (T1-2N1 OR T3N0) breast cancer: a systematic review and... |
tcr.amegroups.com/article/view/33495 | Prevalence, risk factors and prognostic value of anxiety and depression in cervical cancer patients underwent surgery |
tcr.amegroups.com/article/view/33496 | miR-486 as an unfavorable prognostic biomarker for patients with non-small cell lung cancer |
tcr.amegroups.com/article/view/33515 | Identification of the differentially expressed proteins in nasopharyngeal carcinoma by proteomics |
tcr.amegroups.com/article/view/33554 | expression resulting in a poor prognosis in esophageal squamous cell carcinoma by bioinformatics analyses |
tcr.amegroups.com/article/view/33672 | Prognosis and clinicopathological characteristics of renal cell carcinoma: does bilateral occurrence influence overall and cance... |
tcr.amegroups.com/article/view/33674 | Cyclin-dependent kinase 6 (CDK6) is a candidate diagnostic biomarker for early non-small cell lung cancer |
tcr.amegroups.com/article/view/33681 | HIF2A overexpression reduces cisplatin sensitivity in cervical cancer by inducing excessive autophagy |
tcr.amegroups.com/article/view/33710 | investigation of KIN-193 anti-tumor effects on nasopharyngeal carcinoma |
tcr.amegroups.com/article/view/33728 | Survival analyses and immunohistochemical study of primary signet ring cell carcinoma of the lung adenocarcinoma |
tcr.amegroups.com/article/view/33834 | Immunomodulatory features of radiotherapy in lung carcinoma |
tcr.amegroups.com/article/view/33838 | Diagnostic value of glypican 3, arginase-1 and hepatocyte paraffin antigen -1 in differentiating hepatocellular carcinoma from i... |
tcr.amegroups.com/article/view/33859 | Clinical features and prognosis analysis of 57 patients with primary tracheal tumors |
tcr.amegroups.com/article/view/33930 | CENPE promotes glioblastomas proliferation by directly binding to WEE1 |
tcr.amegroups.com/article/view/34025 | Postoperative carcinoembryonic antigen (CEA) levels predict outcomes after resection of colorectal cancer in patients with norma... |
tcr.amegroups.com/article/view/34026 | Dose accumulation in IMRT for left breast cancer determined by applying deformation registration |
tcr.amegroups.com/article/view/34031 | The prognostic value of tumor budding in laryngeal squamous cell carcinoma |
tcr.amegroups.com/article/view/34078 | Exploring and validating the clinical risk factors for pancreatic cancer in chronic pancreatitis patients using electronic medic... |
tcr.amegroups.com/article/view/34079 | Widowed status predicts poor overall survival of Chinese patients with prostate cancer |
tcr.amegroups.com/article/view/34080 | Clinical significance of PI3 and HLA-DOB as potential prognostic predicators for ovarian cancer |
tcr.amegroups.com/article/view/34082 | Clinical value of prostate-specific antigen combined with tumor abnormal protein (TAP) in the diagnosis of prostate puncture |
tcr.amegroups.com/article/view/34097 | Effect of prone and supine treatment positions for postoperative treatment of rectal cancer on target dose coverage and small bo... |
tcr.amegroups.com/article/view/34124 | Necroptosis of osteoblasts was induced by breast cancer cells in vitro |
tcr.amegroups.com/article/view/34136 | Synergistic effects of bevacizumab in combination with β-elemene on subcutaneous xenografts derived from HCT-116 human colon can... |
tcr.amegroups.com/article/view/34144 | The clinicopathological study of lung cancer concealed in end-stage of interstitial lung disease |
tcr.amegroups.com/article/view/34145 | Long-term survival results of patients with locally advanced gastric cancer and pathological complete response after neoadjuvant... |
tcr.amegroups.com/article/view/34146 | Prognostic significance of artemin in gastric cancer and its role in tumorigenesis |
tcr.amegroups.com/article/view/34147 | Correlation between miR-138-5p expression and efficacy of platinum-based chemotherapy in advanced gastric cancer patients |
tcr.amegroups.com/article/view/34173 | Effect of curcumin-lipiodol emulsion combined with absorbable anti- adhesion film through double embolic pathway on angiogenesis... |
tcr.amegroups.com/article/view/34208 | SRC-1 and Twist1 are prognostic indicators of liver cancer and are associated with cell viability, invasion, migration and epith... |
tcr.amegroups.com/article/view/34340 | Association of CMYC polymorphisms with hepatoblastoma risk |
tcr.amegroups.com/article/view/34347 | Pancreatic cancer differential methylation atlas in blood, peri-carcinomatous and diseased tissue |
tcr.amegroups.com/article/view/34348 | infection in a Chinese population |
tcr.amegroups.com/article/view/34404 | Neoadjuvant systemic therapy does not compromise local control after breast-conserving surgery: a single-center, propensity scor... |
tcr.amegroups.com/article/view/34435 | Systematic review and meta-analysis of the clinical survival significance of Sialyl-Tn expression in histological tissues from c... |
tcr.amegroups.com/article/view/34462 | Treatment completion rates and toxicity of 5 fractions of adjuvant radiotherapy over one week in elderly breast cancer patients ... |
tcr.amegroups.com/article/view/34463 | Cyclin-dependent kinase 4/6 inhibitor in combination with endocrine therapy versus endocrine therapy only for advanced breast ca... |
tcr.amegroups.com/article/view/34470 | Benchmarking of electron beam parameters based on Monte Carlo linear accelerator simulation |
tcr.amegroups.com/article/view/34472 | Measuring serum human epididymis secretory protein autoantibody as an early biomarker of lung cancer |
tcr.amegroups.com/article/view/34599 | Prolactin (PRL), placenta growth factor (PIGF) and nerve growth factor receptor (NGFR) as biomarkers for early diagnosis and pro... |
tcr.amegroups.com/article/view/34600 | Thymidylate synthase (TS) immunostaining in the diagnosis of the myoepithelial cells, basal cells, stratified epithelium cells, ... |
tcr.amegroups.com/article/view/34601 | Next generation sequencing of cell free circulating tumor DNA in blood samples of recurrent and metastatic head and neck cancer ... |
tcr.amegroups.com/article/view/34602 | Construction of dysregulated long non-coding RNA-associated competing endogenous RNA network in uterine corpus endometrial carci... |
tcr.amegroups.com/article/view/34605 | Modified subcutaneous suction drainage to prevent incisional surgical site infections after radical colorectal surgery |
tcr.amegroups.com/article/view/34632 | Neoadjuvant therapy does not adversely affect the short-term outcome of critically ill cancer patients who underwent surgery |
tcr.amegroups.com/article/view/34633 | Long-term treatment results and prognostic factors of synchronous and metachronous squamous cell carcinoma of head and neck and ... |
tcr.amegroups.com/article/view/34642 | Correlations of AKIP1, CXCL1 and CXCL2 expressions with clinicopathological features and survival profiles in cervical cancer pa... |
tcr.amegroups.com/article/view/34756 | Correction of spurious low platelet counts by optical fluorescence platelet counting of BC-6800 hematology analyzer in EDTA-depe... |
tcr.amegroups.com/article/view/34758 | Neoadjuvant chemotherapy-induced severe neutropenia is associated with histopathological response and survival in locally advanc... |
tcr.amegroups.com/article/view/34759 | Inhibition of osteopontin overcomes acquired resistance to afatinib in EGFR-mutant non-small-cell lung cancer |
tcr.amegroups.com/article/view/34760 | The overexpression of ZWINT in integrated bioinformatics analysis forecasts poor prognosis in breast cancer |
tcr.amegroups.com/article/view/34761 | Functional analysis of long-chain non-coding RNA in oral squamous cell carcinoma |
tcr.amegroups.com/article/view/30019 | Breast radiotherapy in elderly women: myths, controversies, and current techniques in the adjuvant setting |
tcr.amegroups.com/article/view/30093 | Treatment and patient related quality of life issues in elderly and very elderly breast cancer patients |
tcr.amegroups.com/article/view/30152 | FDG-PET/CT in breast cancer recurrence |
tcr.amegroups.com/article/view/30154 | Stereotactic radiation therapy for breast cancer in the elderly |
tcr.amegroups.com/article/view/30156 | Partial breast irradiation: when less could be more |
tcr.amegroups.com/article/view/30177 | Can elderly patients with low-risk breast cancer benefit from radiotherapy? |
tcr.amegroups.com/article/view/30206 | The role of radiation therapy and systemic therapies in elderly with breast cancer |
tcr.amegroups.com/article/view/30216 | Accelerated partial breast irradiation in elderly breast cancer patients |
tcr.amegroups.com/article/view/30258 | Controversies of radiation therapy omission in elderly women with early stage invasive breast cancer |
tcr.amegroups.com/article/view/30332 | Post-mastectomy and post-breast conservation surgery pain syndrome: a review of etiologies, risk prediction, and trends in manag... |
tcr.amegroups.com/article/view/30358 | Radiation therapy for the elderly—change of concepts in breast cancer? |
tcr.amegroups.com/article/view/30463 | Extreme weekly hypofractionation in breast cancer in elderly |
tcr.amegroups.com/article/view/30644 | Quality of life for elderly breast cancer patients: a new regard |
tcr.amegroups.com/article/view/30645 | The management of elderly patients with brain metastases from breast cancer |
tcr.amegroups.com/article/view/30738 | The role of proton beam therapy in the management of elderly breast cancer patients |
tcr.amegroups.com/article/view/31071 | Palliative care access in the elderly metastatic breast cancer population: obstacles and opportunities |
tcr.amegroups.com/article/view/31641 | Stereotactic ablative radiotherapy for oligometastatic breast cancer in elderly patients |
tcr.amegroups.com/article/view/31686 | Adjuvant radiotherapy for low-risk early breast cancer in elderly women: evidence from randomized trials |
tcr.amegroups.com/article/view/32185 | Radiotherapy in elderly patients with breast cancer: a literature review of acute and late toxicity |
tcr.amegroups.com/article/view/32503 | Altered fractionation in radiation therapy for breast cancer in the elderly: are we moving forward? |
tcr.amegroups.com/article/view/32852 | Pros and cons of radiotherapy omission in elderly breast cancer patients following breast conservative surgery |
tcr.amegroups.com/article/view/33254 | Older breast cancer undertreatment: unconscious bias to undertreat—potential role for the international geriatric radiotherapy g... |
tcr.amegroups.com/article/view/33507 | Hypofractionated radiotherapy for elderly breast cancer patients: from early stages disease to local palliation for unresectable... |
tcr.amegroups.com/article/view/33661 | Synergistic effect of metformin and EGFR-TKI in the treatment of non-small cell lung cancer |
tcr.amegroups.com/article/view/33980 | Research progress of cancer stem cells and IL-6/STAT3 signaling pathway in esophageal adenocarcinoma |
tcr.amegroups.com/article/view/34343 | The role of inflammatory cytokines in the development of idiopathic subglottic stenosis |
tcr.amegroups.com/article/view/34606 | Adrenocortical carcinoma: a literature review |
tcr.amegroups.com/article/view/34641 | gene predicted poor prognosis of hepatocellular carcinoma after radical hepatectomy |
tcr.amegroups.com/article/view/34678 | Applications of hyperspectral imaging in the detection and diagnosis of solid tumors |
tcr.amegroups.com/article/view/34762 | An update on Wnt signaling pathway in cancer |
tcr.amegroups.com/article/view/34403 | Sorafenib with or without concurrent transarterial chemoembolization in hepatocellular carcinoma: a cautionary comment of STAH t... |
tcr.amegroups.com/article/view/34627 | Pre-expansion of posterior gastric fascia during laparoscopic radical gastrectomy for gastric cancer prevents injuries to upper ... |
tcr.amegroups.com/article/view/34669 | Long-term survivors with immunotherapy in advanced NSCLC: is ‘cure’ within reach? |
tcr.amegroups.com/article/view/34405 | Rarely seen primary cardiac natural killer/T cell lymphoma: a case report |
tcr.amegroups.com/post/category/focused-issues-published | more |
tcr.amegroups.com/post/view/focused-issue-on-population-scie... | More >> |
tcr.amegroups.com/post/view/focused-issue-on-primary-liver-c... | More >> |
tcr.amegroups.com/post/view/focused-issue-on-targeted-therap... | More >> |
tcr.amegroups.com/post/category/focused-issues-ongoing | more |
tcr.amegroups.com/post/view/focused-issue-on-endometrial-can... | More >> |
tcr.amegroups.com/post/category/book-recommendation | more |
tcr.amegroups.com/post/view/the-book-particle-beam-therapy-c... | More >> |
tcr.amegroups.com/post/category/reviewers | more |
tcr.amegroups.com/post/view/the-reviewers-of-tcr-2019 | More >> |
amegroups.com | <img> |
thestm.org/ | <img> |
acr.amegroups.com/ | AME Case Reports |
amj.amegroups.com/ | AME Medical Journal |
aob.amegroups.com/ | Annals of Blood |
abs.amegroups.com/ | Annals of Breast Surgery |
ace.amegroups.com/ | Annals of Cancer Epidemiology |
annalscts.com/ | Annals of Cardiothoracic Surgery |
aoe.amegroups.com/ | Annals of Esophagus |
aes.amegroups.com/ | Annals of Eye Science |
aoi.amegroups.com/ | Annals of Infection |
aoj.amegroups.com/ | Annals of Joint |
ales.amegroups.com/ | Annals of Laparoscopic and Endoscopic Surgery |
aol.amegroups.com/ | Annals of Lymphoma |
anpc.amegroups.com/ | Annals of Nasopharynx Cancer |
apm.amegroups.com/ | Annals of Palliative Medicine |
arh.amegroups.com/ | Annals of Research Hospitals |
aot.amegroups.com/ | Annals of Thyroid |
atm.amegroups.com/ | Annals of Translational Medicine |
aos.amegroups.com/ | Art of Surgery |
ajo.amegroups.com/ | Australian Journal of Otolaryngology |
biotarget.amegroups.com/ | Biotarget |
cdt.amegroups.com/ | Cardiovascular Diagnosis and Therapy |
cco.amegroups.com/ | Chinese Clinical Oncology |
ccts.amegroups.com/ | Current Challenges in Thoracic Surgery |
dmr.amegroups.com/ | Digestive Medicine Research |
gist.amegroups.com/ | Gastrointestinal Stromal Tumor |
gs.amegroups.com/ | Gland Surgery |
gpm.amegroups.com/ | Gynecology and Pelvic Medicine |
ht.amegroups.com/ | Health Technology |
hbsn.amegroups.com/ | Hepatobiliary Surgery and Nutrition |
jeccm.amegroups.com/ | Journal of Emergency and Critical Care Medicine |
jgo.amegroups.com/ | Journal of Gastrointestinal Oncology |
jhmhp.amegroups.com/ | Journal of Hospital Management and Health Policy |
jlpm.amegroups.com/ | Journal of Laboratory and Precision Medicine |
jmai.amegroups.com/ | Journal of Medical Artificial Intelligence |
jphe.amegroups.com/ | Journal of Public Health and Emergency |
jss.amegroups.com/ | Journal of Spine Surgery |
jtd.amegroups.com/ | Journal of Thoracic Disease |
jovs.amegroups.com/ | Journal of Visualized Surgery |
jxym.amegroups.com/ | Journal of Xiangya Medicine |
ls.amegroups.com/ | Laparoscopic Surgery |
lcm.amegroups.com/ | Longhua Chinese Medicine |
med.amegroups.com/ | Mediastinum |
map.amegroups.com/ | Mesentery and Peritoneum |
mhealth.amegroups.com/ | mHealth |
mps.amegroups.com/ | Microphysiological Systems |
ncri.amegroups.com/ | Non-coding RNA Investigation |
pm.amegroups.com/ | Pediatric Medicine |
pcm.amegroups.com/ | Precision Cancer Medicine |
qims.amegroups.com/ | Quantitative Imaging in Medicine and Surgery |
shc.amegroups.com/ | Shanghai Chest |
sci-online.org/ | Stem Cell Investigation |
tro.amegroups.com/ | Therapeutic Radiology and Oncology |
tau.amegroups.com/ | Translational Andrology and Urology |
tgh.amegroups.com/ | Translational Gastroenterology and Hepatology |
tlcr.amegroups.com/ | Translational Lung Cancer Research |
tp.amegroups.com/ | Translational Pediatrics |
vats.amegroups.com/ | Video-Assisted Thoracic Surgery |
whi.amegroups.com/ | Women’s Health Investigation |
amegroups.com/medicine-service | More Journal |
Внутренние ссылки главной страницы ( 30 ) | |
/ | - |
/pages/view/indexing | Indexing |
/pages/view/co-editor-in-chief | Co-Editor-in-Chief |
/pages/view/associate-editor-in-chief | Associate Editors-in-Chief |
/pages/view/editorial-policies | Editorial Policies |
thetcr.org/announcement/view/89 | Read More>> |
/pages/view/submit-multimedia-files | Submit Multimedia Files |
/public/system/tcr/tcr-instruction-for-authors.pdf | Author Instruction |
/public/addition/default/reference-style.ens | Reference Style |
/public/system/tcr/tcr-publication-ethics.pdf | Publication Ethics |
/pages/view/conflict-of-interest | Conflict of Interest |
/pages/view/human-animal-rights | Human and Animal Rights |
/pages/view/informed-consent | Informed Consent |
/pages/view/data-sharing-policy | Data Sharing Policy |
/pages/view/peer-review-process | Peer Review Process |
/public/system/tcr/reviewer-instruction.pdf | Reviewer Instruction |
/post/category/reviewers | Reviewers |
/post/category/focused-Issues-published | Focused Issues (Published) |
/post/category/focused-Issues-ongoing | Focused Issues (Ongoing) |
/pages/view/article-processing-charges | Article Processing Charges |
/post/view/focused-issue-on-endometrial-cancer | Read More>> |
/announcement/view/244 | Read More>> |
/post/view/focused-issue-on-radiotherapy-for-breast-cancer-i... | Read More>> |
/announcement/view/223 | Read More>> |
/post/view/focused-issue-on-recent-developments-in-benign-tr... | Read More>> |
/post/view/focused-issue-on-rare-tumors-of-the-breast | Read More>> |
/issue/view/375 | Read More>> |
/issue/view/360 | Read More>> |
/about | more |
/announcement/view/105 | <img> |
Domain Name:THETCR.ORG
Domain ID: D160120633-LROR
Creation Date: 2010-09-11T15:25:12Z
Updated Date: 2013-04-10T08:35:20Z
Registry Expiry Date: 2015-09-11T15:25:12Z
Sponsoring Registrar:GoDaddy.com, LLC (R91-LROR)
Sponsoring Registrar IANA ID: 146
WHOIS Server:
Referral URL:
Domain Status: clientDeleteProhibited
Domain Status: clientRenewProhibited
Domain Status: clientTransferProhibited
Domain Status: clientUpdateProhibited
Registrant ID:CR86335194
Registrant Name:STEPHEN WANG
Registrant Organization:PBPC
Registrant Street: 8/F, CNT Comm Building,302 Queen's Road
Registrant City:HONG KONG
Registrant State/Province:
Registrant Postal Code:000000
Registrant Country:HK
Registrant Phone:+852.21393077
Registrant Phone Ext:
Registrant Fax:
Registrant Fax Ext:
Registrant Email:swang@thepbpc.org
Admin ID:CR86335205
Admin Name:STEPHEN WANG
Admin Organization:PBPC
Admin Street: 8/F, CNT Comm Building,302 Queen's Road
Admin City:HONG KONG
Admin State/Province:
Admin Postal Code:000000
Admin Country:HK
Admin Phone:+852.21393077
Admin Phone Ext:
Admin Fax:
Admin Fax Ext:
Admin Email:swang@thepbpc.org
Tech ID:CR86335199
Tech Name:STEPHEN WANG
Tech Organization:PBPC
Tech Street: 8/F, CNT Comm Building,302 Queen's Road
Tech City:HONG KONG
Tech State/Province:
Tech Postal Code:000000
Tech Country:HK
Tech Phone:+852.21393077
Tech Phone Ext:
Tech Fax:
Tech Fax Ext:
Tech Email:swang@thepbpc.org
Name Server:F1G1NS1.DNSPOD.NET
Name Server:F1G1NS2.DNSPOD.NET
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Access to Public Interest Registry WHOIS information is provided to assist persons in determining the contents of a domain name registration record in the Public Interest Registry registry database. The data in this record is provided by Public Interest Registry for informational purposes only, and Public Interest Registry does not guarantee its accuracy. This service is intended only for query-based access. You agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to(a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of Registry Operator, a Registrar, or Afilias except as reasonably necessary to register domain names or modify existing registrations. All rights reserved. Public Interest Registry reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy.
Нидерланды - 145.36.42.28
Elsevier Limited
SURFnet
HTTP/1.1 200 OK
Server: nginx
Date: Mon, 06 Jan 2020 12:26:17 GMT
Content-Type: text/html; charset=utf-8
Transfer-Encoding: chunked
Connection: keep-alive
Vary: Accept-Encoding
X-Powered-By: PHP/5.5.9-1ubuntu4.29
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"